drugset
drugset / Trial / NCT06393413

To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease

NCT06393413 ↗

Phase 0 Completed 62 enrolled Changchun University of Chinese Medicine
RandomizedSingle-groupOpen-labelTreatment

Summary

AD patients who met the inclusion criteria in the encephalopathy clinic and treatment area of the Third Clinical Hospital Affiliated to Changchun University of Traditional Chinese Medicine from December 2022 to December 2023 were collected and randomly divided into traditional Chinese medicine experimental group and western medicine control group. The experimental group was treated with Jiedu Yizhi Formula, and the control group was treated with Donepezil Hydrochloride Tablets ( trade name : Aricept ). The two groups were given AD cognitive behavior training and health education at the same time. The course of treatment was 24 weeks. The Western medicine scale was measured before treatment, 12 weeks after treatment and 24 weeks after treatment to evaluate the effect of drugs on cognitive function and daily living ability.

Timeline

Start
2022-12-01
Primary completion
2023-12-01
Completion
2024-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Donepezil Small molecule 10 mg Oral
Subject Jiedu Yizhi Formula Traditional medicine (herbal / TCM) 100 ml Oral

Indications

No indication recorded.